Intech Biopharm Corporation logo

Intech Biopharm Corporation (6461)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
15. 90
-0.05
-0.3135%
NT$
- Market Cap
- P/E Ratio
- Div Yield
115,833 Volume
- Eps
NT$ 15.95
Previous Close
Add Transaction
Day Range
15.8 16.05
Year Range
14.1 26.25
Want to track 6461 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Upcoming 6461 split of 309:500 in 22 days (2 Sep 2026)

Intech Biopharm Corporation (6461) Statistics

Valuation metrics

Market Cap -
Enterprise value 4.16B
Trailing P/E (ttm) -6.79
Forward P/E -
PEG ratio -0.64
Price/Sales (ttm) 25.05
Price/Book (mrq) 2.96
Enterprise Value/Revenue 35.42
Enterprise Value/EBITDA -14.41

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 155.05K
Average volume (90 days) 209.19K

Price summary

52-Week low 14.1
52-Week high 26.25
Beta -
50-Day moving average 15.6
200-Day moving average 17.84

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 513:500
Last split Date 26 Sep 2023

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -3.51%
Operating margin -3.31%

Operational effectiveness

Return on assets -0.18%
Return on equity -0.39%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.66
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.32
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.08
Total debt (mrq) -
Total Debt/Equity (mrq) 1.28
Current ratio (mrq) 0.96%
Book value per share (mrq) 5.57

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -